Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CONy 2020 | Treating MS: new therapies and COVID-19

Abhijit Chaudhuri, DM, MD, PhD, FACP, FRCP, FEAN, Queen’s Hospital, Romford, UK, discusses recent innovations in multiple sclerosis (MS). In light of the pandemic, therapeutic strategies have been changed to limit hospital visits and enable high efficacy home treatment. There have also been developments in monoclonal antibodies that do not require intravenous administration, such as ofatumumab. Additionally, for progressive forms of MS, ocrelizumab is now an option. This interview took place during the Virtual World Congress on Controversies in Neurology (CONy) 2020.


Abhijit Chaudhuri has received travel grants, honoraria and speaker fee from Merck, Bial and Eisai in the past two years.